Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
By M. Law, T. Maruyama, Jamie T. Lewis, E. Giang, A. Tarr, Z. Stamataki, P. Gastaminza, F. Chisari, I. Jones, R. Fox and 4 more. Nature Medicine, 2008
629 citations recorded by the source corpus.
Subfields: Epidemiology, Hepatology, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/c53a045978ac492a4f421a1740d031b9bf9f85fe
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- L. Walker
- T. Wrin
- M. Simek
- W. Rida
- P. Poignard
- F. Priddy
- P. Pung
- E. Carrow
Citations in the corpus
- Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm (2009, background): “the envelope is a major issue in vaccine design (13, 27, 48).”